Early ctDNA reduction in metastatic uveal melanoma correlates better with OS than RECIST response Presented ByDr Alexander Shoushtari, Memorial Sloan Kettering Cancer Center, NY, USA TrialPhase 1/2, IMCgp100-202 ConferenceESMO 2021 19 November, 2021 09:09
